Evidence map›Paper›PMID 30657642›Full record

ArticleJournal of the International AIDS Society2019

Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.

Edith Nakku-Joloba, Emily E Pisarski, Monique A Wyatt, Timothy R Muwonge, Stephen Asiimwe, Connie L Celum, Jared M Baeten, Elly T Katabira, Norma C Ware

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02775929 (An Open Label, Pilot Demonstration and Evaluation Project of Antiretroviral-based HIV-1 Prevention Among High-risk Serodiscordant African Couples), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02775929 phase4completednot on this map

An Open Label, Pilot Demonstration and Evaluation Project of Antiretroviral-based HIV-1 Prevention Among High-risk Serodiscordant African Couples

TypeinterventionalSponsorUniversity of WashingtonRan2012 to 2016Enrolled1,013ConditionsHIV InfectionArmsFTC-TDF PrEP, ART
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Edith Nakku-JolobaDepartment of Epidemiology and Biostatistics, Makerere University College of Health Sciences, Kampala, Uganda.
Emily E PisarskiDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Monique A WyattDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Timothy R MuwongeInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Stephen AsiimweKabwohe Clinical Research Centre, Kabwohe, Uganda.
Connie L CelumDepartments of Global Health, Medicine, and Epidemiology, School of Medicine and School of Public Health, University of Washington, Seattle, WA, USA.ORCID 0000-0002-8813-3419
Jared M BaetenDepartments of Global Health, Medicine, and Epidemiology, School of Medicine and School of Public Health, University of Washington, Seattle, WA, USA.ORCID 0000-0001-8242-8438
Elly T KatabiraDepartment of Medicine, Makerere University, Kampala, Uganda.
Norma C WareDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-5039-9991

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Optimizing Antiretroviral-Based HIV Prevention for HIV Serodiscordant CouplesR01MH095507 · NIMH · UNIVERSITY OF WASHINGTON · PI BAETEN, JARED · 2011 to 2020
$6.1M
Optimizing Delivery of ART/PrEP for HIV Prevention through Qualitative ResearchR01MH101027 · NIMH · HARVARD MEDICAL SCHOOL · PI KATABIRA, ELLY T, WARE, NORMA C · 2013 to 2016
$2.2M
NIAID NIH HHS P30 AI027757NIMH NIH HHS R01 MH095507NIMH NIH HHS R01 MH101027
6 · The paper itself

Abstract

introductionPre-exposure prophylaxis (PrEP) to prevent HIV infection is being rolled out in Africa. The uptake of PrEP to date has varied across populations and locations. We seek to understand the drivers of demand for PrEP through analysis of qualitative data collected in conjunction with a PrEP demonstration project involving East African HIV serodiscordant couples. Our goal was to inform demand creation by understanding what PrEP means - beyond HIV prevention - for the lives of users.

methodsThe Partners Demonstration Project evaluated an integrated strategy of PrEP and antiretroviral therapy (ART) delivery in which time-limited PrEP served as a "bridge" to long-term ART. Uninfected partners in HIV serodiscordant couples were offered PrEP at baseline and encouraged to discontinue once infected partners had taken ART for six months. We conducted 274 open-ended interviews with 93 couples at two Ugandan research sites. Interviews took place one month after enrolment and at later points in the follow-up period. Topics included are as follows: (1) discovery of serodiscordance; (2) decisions to accept/decline PrEP and/or ART; (3) PrEP and ART initiation; (4) experiences of using PrEP and ART; (5) PrEP discontinuation; (6) impact of PrEP and ART on the partnered relationship. Interviews were audio-recorded and transcribed. We used an inductive, content analytic approach to characterize meanings of PrEP stemming from its effectiveness for HIV prevention. Relevant content was represented as descriptive categories.

resultsDiscovery of HIV serodiscordance resulted in fear of HIV transmission for couples, which led to loss of sexual intimacy in committed relationships, and to abandonment of plans for children. As a result, partners became alienated from each other. PrEP countered the threat to the relationship by reducing fear and reinstating hopes of having children together. Condom use worked against the re-establishment of intimacy and closeness. By increasing couples' sense of protection against HIV infection and raising the prospect of a return to "live sex" (sex without condoms), PrEP was perceived by couples as solving the problem of serodiscordance and preserving committed relationships.

conclusionsThe most effective demand creation strategies for PrEP may be those that address the everyday life priorities of potential users in addition to HIV prevention. CLINICAL TRIAL NUMBER: NCT02775929.

Indexed as

AdultAnti-HIV AgentsFemaleHIV InfectionsHumansMaleMotivationPre-Exposure ProphylaxisQualitative ResearchSafe SexSexual PartnersUgandaAnti-HIV Agentsdemand creationEast AfricaHIVPrEPpreventionserodiscordant couples

Identifiers

PMID30657642
PMCPMC6338102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.